REGISTERED
on 02 Feb 2021
Last Applicant/ Owned by
170 PARK AVENUE
FLORHAM PARK
NJ
07932
Serial Number
90002793 filed on 15th Jun 2020
Registration Number
6260135 registered on 02th Feb 2021
Correspondent Address
Camille M. Miller
Filing Basis
1. use application currently
Disclaimer
NO DATA
CELULARITY
Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human Read More
Classification Information
Class [001]
Chemical Products
bioengineered cells for use in scientific, laboratory and medical research; human allograft tissue made from human umbilical cords and human placentas for use in scientific, laboratory and medical research
First Use Date in General
06th Dec 2018
First Use Date in Commerce
06th Dec 2018
Class [005]
Pharmaceutical Products
Cells and biological preparations intended for medical and clinical use, namely, blood, stem cells, umbilical cord cells, umbilical cord blood, and placental allograft tissue; bioengineered cells for use in immunotherapies for cancer and other diseases; human allograft tissue made from human umbilical cords and human placentas intended for subsequent implantation; human amniotic membrane and human chorionic membrane intended for subsequent implantation; human collagen compositions and extracellular matrix compositions intended for subsequent implantation; biological products for medical use, namely, placental-derived natural killer cells, and placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen;biological tissue intended for use as a wound covering; wound dressings; burn dressings; surgical dressings; pharmaceutical preparations for wounds; and written instructional materials distributed in connection with the aforesaid goods; biological products for medical use, namely, placental-derived cytotoxic T cells with a chimeric antigen receptor (CAR) specific for a cancer or other disease-associated antigen
First Use Date in General
06th Dec 2018
First Use Date in Commerce
06th Dec 2018
Mark Details
Serial Number
No 90002793
Mark Type
No Service/Collective Mark
Attorney Docket Number
No CLTY0512US2
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 12th Jan 2022 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| 02th Feb 2021 | REGISTERED-PRINCIPAL REGISTER |
| 17th Nov 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 17th Nov 2020 | PUBLISHED FOR OPPOSITION |
| 28th Oct 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 09th Oct 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 08th Oct 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 08th Oct 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 08th Oct 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 16th Sep 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |